Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type (2014-2025) 1.4.2 Vitamin E & Pioglitazone 1.4.3 Ocaliva 1.4.4 Elafibranor 1.4.5 Selonsertib & Cenicriviroc 1.5 Market by Application 1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacy 1.5.3 Online Provider 1.5.4 Retail Pharmacy   1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Nonalcoholic Steatohepatitis (NASH) Market Size 2.2 Nonalcoholic Steatohepatitis (NASH) Growth Trends by Regions 2.2.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2014-2025) 2.2.2 Nonalcoholic Steatohepatitis (NASH) Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Manufacturers 3.1.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2014-2019) 3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI) 3.2 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served 3.3 Key Players Nonalcoholic Steatohepatitis (NASH) Product/Solution/Service 3.4 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) 4.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) 5 United States 5.1 United States Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 5.2 Nonalcoholic Steatohepatitis (NASH) Key Players in United States 5.3 United States Nonalcoholic Steatohepatitis (NASH) Market Size by Type 5.4 United States Nonalcoholic Steatohepatitis (NASH) Market Size by Application 6 Europe 6.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 6.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Europe 6.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type 6.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application 7 China 7.1 China Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 7.2 Nonalcoholic Steatohepatitis (NASH) Key Players in China 7.3 China Nonalcoholic Steatohepatitis (NASH) Market Size by Type 7.4 China Nonalcoholic Steatohepatitis (NASH) Market Size by Application 8 Japan 8.1 Japan Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 8.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Japan 8.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type 8.4 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 9.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Southeast Asia 9.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type 9.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application 10 India 10.1 India Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 10.2 Nonalcoholic Steatohepatitis (NASH) Key Players in India 10.3 India Nonalcoholic Steatohepatitis (NASH) Market Size by Type 10.4 India Nonalcoholic Steatohepatitis (NASH) Market Size by Application 11 Central & South America 11.1 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019) 11.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Central & South America 11.3 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type 11.4 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application 12 International Players Profiles 12.1 Tobira Therapeutics 12.1.1 Tobira Therapeutics Company Details 12.1.2 Company Description and Business Overview 12.1.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.1.4 Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.1.5 Tobira Therapeutics Recent Development 12.2 Cadila Healthcare 12.2.1 Cadila Healthcare Company Details 12.2.2 Company Description and Business Overview 12.2.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.2.4 Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.2.5 Cadila Healthcare Recent Development 12.3 Conatus Pharmaceuticals 12.3.1 Conatus Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.3.4 Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.3.5 Conatus Pharmaceuticals Recent Development 12.4 Galmed Pharmaceuticals 12.4.1 Galmed Pharmaceuticals Company Details 12.4.2 Company Description and Business Overview 12.4.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.4.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.4.5 Galmed Pharmaceuticals Recent Development 12.5 Gemphire Therapeutics 12.5.1 Gemphire Therapeutics Company Details 12.5.2 Company Description and Business Overview 12.5.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.5.4 Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.5.5 Gemphire Therapeutics Recent Development 12.6 Genfit 12.6.1 Genfit Company Details 12.6.2 Company Description and Business Overview 12.6.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.6.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.6.5 Genfit Recent Development 12.7 Gilead Sciences 12.7.1 Gilead Sciences Company Details 12.7.2 Company Description and Business Overview 12.7.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.7.4 Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.7.5 Gilead Sciences Recent Development 12.8 Intercept Pharmaceuticals 12.8.1 Intercept Pharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.8.4 Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.8.5 Intercept Pharmaceuticals Recent Development 12.9 Novartis International 12.9.1 Novartis International Company Details 12.9.2 Company Description and Business Overview 12.9.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.9.4 Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.9.5 Novartis International Recent Development 12.10 Shire 12.10.1 Shire Company Details 12.10.2 Company Description and Business Overview 12.10.3 Nonalcoholic Steatohepatitis (NASH) Introduction 12.10.4 Shire Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) 12.10.5 Shire Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Nonalcoholic Steatohepatitis (NASH) Key Market Segments Table Key Players Nonalcoholic Steatohepatitis (NASH) Covered Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type 2014-2025 Figure Vitamin E & Pioglitazone Figures Table Key Players of Vitamin E & Pioglitazone Figure Ocaliva Figures Table Key Players of Ocaliva Figure Elafibranor Figures Table Key Players of Elafibranor Figure Selonsertib & Cenicriviroc Figures Table Key Players of Selonsertib & Cenicriviroc Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacy Case Studies Figure Online Provider Case Studies Figure Retail Pharmacy   Case Studies Figure Nonalcoholic Steatohepatitis (NASH) Report Years Considered Table Global Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2025 (Million US$) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate 2014-2025 (Million US$) Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2014-2025 (Million US$) Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2014-2019 (Million US$) Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2014-2019 Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2014-2019 Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2019 Table Market Top Trends Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2014-2019) (Million US$) Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Manufacturers (2014-2019) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Manufacturers in 2018 Table Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Nonalcoholic Steatohepatitis (NASH) Product/Solution/Service Table Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market Table Mergers & Acquisitions, Expansion Plans Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Type (2014-2019) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2014-2019) Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Application (2014-2019) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2014-2019) Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application in 2018 Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table United States Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table United States Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table United States Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table United States Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table United States Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table United States Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table Europe Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table Europe Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Figure China Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table China Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table China Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table China Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-20189) (Million US$) Table China Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table China Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table China Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table Japan Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table Japan Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table Japan Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table Japan Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Figure India Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table India Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table India Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table India Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table India Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table India Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table India Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Figure Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$) Table Central & South America Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$) Table Central & South America Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019) Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$) Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019) Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$) Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019) Table Tobira Therapeutics Company Details Table Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) (Million US$) Figure Tobira Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Tobira Therapeutics Recent Development Table Cadila Healthcare Company Details Table Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Cadila Healthcare Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Cadila Healthcare Recent Development Table Conatus Pharmaceuticals Company Details Table Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Conatus Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Conatus Pharmaceuticals Recent Development Table Galmed Pharmaceuticals Company Details Table Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Galmed Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Galmed Pharmaceuticals Recent Development Table Gemphire Therapeutics Company Details Table Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Gemphire Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Gemphire Therapeutics Recent Development Table Genfit Company Details Table Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Genfit Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Genfit Recent Development Table Gilead Sciences Company Details Table Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Gilead Sciences Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Gilead Sciences Recent Development Table Intercept Pharmaceuticals Company Details Table Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Intercept Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Intercept Pharmaceuticals Recent Development Table Novartis International Company Details Table Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Novartis International Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Novartis International Recent Development Table Shire Company Details Table Shire Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$) Figure Shire Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) Table Shire Recent Development Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (Million US$) 2019-2025 Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Regions (2019-2025) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Regions in 2025 Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Figure China Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Figure India Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD) Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product (2019-2025) (Million US$) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product (2019-2025) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product in 2025 Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2025) (Million US$) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2025) Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Tobira Therapeutics Cadila Healthcare Conatus Pharmaceuticals Galmed Pharmaceuticals Gemphire Therapeutics Genfit Gilead Sciences Intercept Pharmaceuticals Novartis International Shire